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        Introduction 
  Activation of Cdc2 and its translocation to the nucleus are the 
crucial events controlling entry into mitosis (  Nurse, 1990  ;   Hunt, 
1991 ;   Pines,  1999 ;   Takizawa and Morgan, 2000  ). In multicellu-
lar eukaryotes, the kinase activity of Cdc2 is generally consid-
ered to be regulated by inhibitory phosphorylation on Thr14 
and Tyr15, which are catalyzed by Wee1 and Myt1 (  Lew and 
Kornbluth, 1996  ;   Nigg, 2001  ). Wee1, which was identifi  ed orig-
inally in a   Schizosaccharomyces pombe   mutant with a small cell 
or wee phenotype, is a tyrosine-specifi  c protein kinase con-
served in all eukaryotes. Human Wee1 is nuclear and phosphory-
lates Cdc2 exclusively on Tyr15 (  Parker and Piwnica-Worms, 
1992  ;   Heald et al., 1993  ;   McGowan and Russell, 1993  ;   Parker 
et al., 1995  ). Myt1, a membrane-associated kinase, is present in 
metazoans and phosphorylates Cdc2 on both Thr14 and Tyr15 
residues (  Kornbluth et al., 1994  ;   Mueller et al., 1995  ;   Booher 
et al., 1997  ;   Liu et al., 1997, 1999  ;   Wells et al., 1999  ;   Okumura 
et al., 2002  ). Thus, both Myt1 and Wee1 have been thought to 
function as negative regulators of mitotic entry. 
  In several known species, Myt1 but not Wee1 is present in 
immature oocytes and mediates prophase I arrest by inhibiting 
Cdc2 (  Nakajo et al., 2000  ;   Okumura et al., 2002  ). In   Xenopus  
  laevis   oocytes, injection of neutralizing anti-Myt1 antibodies 
induces germinal vesicle breakdown, presumably through the 
activation of Cdc2 (  Nakajo et al., 2000  ). In   Caenorhabditis 
elegans   hermaphrodites, Myt1 depletion using RNAi has been 
shown to cause precocious maturation of oocytes (  Burrows 
et al., 2006  ). Mutations in Myt1 in   C. elegans   also implicate its 
role in the regulation of male meiosis (  Lamitina and L  ’  Hernault, 
2002 ).  Furthermore,   Drosophila    melanogaster   Myt1 has been 
shown to be important for the regulation of both mitotic and 
meiotic cell cycles during gametogenesis (  Jin et al., 2005  ). 
More proliferating cells were observed in null   myt1   mutant tes-
tes and ovaries than in controls, and male   myt1   mutants  show 
complete sterility. In addition, the loss of Myt1 causes elevated 
nondisjunction in homologous chromosome segregation during 
female meiosis I (  Jin et al., 2005  ). Thus, Myt1 has a pivotal role 
in gametogenesis in various species. However, it is not known 
whether Myt1 functions to regulate mitotic entry during somatic 
cell cycles in vertebrates. 
  In this study, we examine the role of Myt1 in mammalian 
somatic cell cycles. Our results show that although the inhibition 
of Wee1 expression by siRNA markedly accelerates mitotic entry, 
inhibition of Myt1 expression does not change the timing of mi-
totic entry. Interestingly, our analysis demonstrates that Myt1 de-
pletion induces severe defects in Golgi and ER assembly during 
mitotic exit. Thus, Myt1 is essential for Golgi and ER assembly at 
the end of mitosis. Furthermore, cyclin B1 and B2 knockdown 
experiments demonstrate that Myt1 functions to facilitate Golgi 
and ER assembly through its ability to suppress both cyclin B1  –   
and cyclin B2  –  Cdc2 activities. Thus, our fi  ndings have identifi  ed 
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transition. As previously reported, the mobility of Myt1 is reduced 
on SDS gels as a result of phosphorylation during M phase ( Mueller 
et al., 1995 ;  Booher et al., 1997 ;  Liu et al., 1997, 1999 ;  Wells et al., 
1999  ;   Okumura et al., 2002  ). To exclude the possibility that the 
antibody used might recognize slower migrating forms of Myt1 
more strongly, we examined Myt1 protein levels after treating cell 
extracts with      phosphatase. The result also shows that Myt1 pro-
tein levels increase during M phase ( Fig. 1 A , top right). Moreover, 
the decrease of Myt1 observed after M phase was markedly sup-
pressed by treatment with MG132, a proteasome inhibitor ( Fig. 1 A , 
bottom right), indicating that Myt1 degradation directly or in-
directly requires the ubiquitin-proteasome system at the end of M 
phase or during G1 phase. 
  To examine the role of Myt1 in mitotic entry in somatic 
cell cycles, siRNA was used to reduce Myt1 levels in synchronized 
Myt1 as an essential regulator of intracellular membrane dy-
namics during mitosis in mammalian somatic cell cycles. 
  Results 
  The effects of Myt1 and Wee1 siRNAs on 
the timing of mitotic entry in HeLa cells 
  To determine whether human Myt1 levels vary throughout the so-
matic cell cycle, we examined Myt1 protein levels in synchro-
nized HeLa cells. Myt1 levels peaked at M phase, at 9  –  11 h after 
release from a thymidine block, and markedly decreased after M 
phase (  Fig. 1 A  , top left). In contrast to cyclin B1, whose protein 
levels peaked at 9 h and dropped rapidly, Myt1 protein levels re-
mained high at 10  –  11 h, indicating that Myt1 is present at rela-
tively high levels during M phase even after the metaphase-anaphase 
  Figure 1.       The effect of Myt1 and Wee1 siRNAs on the timing of mitotic entry in HeLa cells.   (A) Extracts were prepared from HeLa cells synchronized by 
a double-thymidine block and analyzed by SDS-PAGE followed by immunoblotting with anti-Myt1, anti  –  cyclin B1, and anti  –      -tubulin antibodies (top and 
bottom left). MG132 was added to synchronized cells 8 h after release (bottom right). Extracts from synchronized cells were treated with or without      
protein phosphatase and were subjected to immunoblotting with anti-Myt1 and anti  –      -tubulin antibodies (top right). (B) HeLa cells were transfected with 
Myt1 or Wee1 siRNA in the interval between the two thymidine blocks (top; experimental protocol). Cell extracts were analyzed by SDS-PAGE followed 
by immunoblotting with anti-Myt1, anti-Wee1, and anti  –      -tubulin antibodies (bottom left). The cells were examined for the percentage of mitotic cells using 
antiphosphohistone H3 antibody (bottom right). More than 300 cells were examined, and the percentages are shown as mitotic index.     91  M  YT  1 IS ESSENTIAL FOR GOLGI AND ER ASSEMBLY   •   NAKAJIMA ET AL.
the actin cytoskeleton and lysosomes were indistinguishable from 
those in control cells (  Fig. 2 B  ). The Golgi apparatus, however, 
displayed a dramatically transformed morphology in Myt1-
  depleted cells. Immunofl  uorescence staining for Golgi matrix 
proteins GM130 and p115 revealed markedly condensed non-
ribbon-like membranous structures near the nucleus, which 
are clearly different from normal Golgi structures in control cells 
(  Fig. 3 A  ) and control siRNA-treated cells (not depicted). Immuno-
fluorescence staining for other Golgi markers, including 
v-SNARE GS15, t-SNARE Vti1a, and Golgin-245/p230, revealed 
similar differences in the staining patterns between Myt1-depleted 
cells and control cells (unpublished data). Furthermore, most ER 
exit sites localized around such Golgi marker  –  positive condensed 
structures (  Fig. 3 C  ). Interestingly,     -adaptin, which localizes to 
the TGN in control cells, rarely associated with these abnormal 
membranous structures in Myt1-depleted cells but rather was dis-
persed throughout the cytoplasm (  Fig. 3 B  ). In Myt1-depleted 
cells, the other TGN markers, Golgin97 and TGN38, were not 
dispersed but associated with the condensed membranous struc-
tures like other cis- and medial-Golgi markers (  Fig. 3 B   and not 
depicted). As     -adaptin is a clathrin adaptor and functions to fa-
cilitate transport from the TGN to both endosomes and the plasma 
membrane, Myt1-depleted cells may be defi  cient in these trans-
porting abilities. A portion of Myt1-depleted cells displayed large 
HeLa cells. HeLa cells were transfected with Myt1 siRNA dur-
ing the interval between the two thymidine blocks (  Fig. 1 B  , 
top). The percentage of mitotic cells was determined using a 
phosphohistone H3 antibody that specifi  cally detects mitotic 
cells. The effect of Wee1 siRNA on the timing of mitotic entry 
was also examined. In untreated control cells, the percentage of 
the mitotic cells peaked at 10 h after release from the G1/S 
block (  Fig. 1 B  ). The Myt1 siRNA-treated cells showed al-
most the same time course of mitotic entry as the control cells, 
whereas the Wee1 siRNA-treated cells entered mitosis much 
earlier than the control and Myt1 siRNA-treated cells (  Fig. 1 B  ). 
Essentially the same results were obtained in another series of 
experiments in which MPM2-positive cells or condensed chromo -
somes were used as the mitotic indices (unpublished data). 
These results suggest that Myt1, unlike Wee1, may be less im-
portant for regulating mitotic entry timing in HeLa cells. 
  Myt1 is necessary for Golgi reassembly 
during telophase 
  In Myt1 siRNA-treated cells, a mitotic spindle was formed nor-
mally, and interphase microtubules emanated from centrosomes 
normally and extended toward the cell periphery, although they 
appeared to be slightly less dense (  Fig. 2 A  ). In these cells, the 
number and size of centrosomes were also apparently normal, and 
  Figure 2.       Effect of Myt1 depletion on cyto-
skeleton and subcellular organelles.   HeLa 
cells were transfected with Myt1 siRNA and 
incubated for 48 h. (A) M-phase (top) and inter-
phase (bottom) cells were stained with anti  –
      -tubulin antibody (green) together with Hoechst 
(blue). (B) Cells were stained with anti  –      -tubulin 
antibody for centrosomes (left), ﬂ   uorescent 
phalloidin for actin cytoskeleton (middle), and 
anti-LAMP1 antibody for lysosomes (right; red) 
together with Hoechst (blue). Bars, 10   μ  m.     JCB • VOLUME 181 • NUMBER 1 • 2008  92 
reassembly during mitotic exit. The Golgi apparatus fragments 
into thousands of vesicles and tubules during prometaphase 
and rapidly reassembles during telophase in mammalian cells 
(  Shorter and Warren, 2002  ). To distinguish between these two 
possibilities, we transfected synchronized HeLa cells with Myt1 
siRNA as in  Fig. 1 B  and stained the cells with anti-GM130 antibody 
vacuoles (unpublished data), which may be the result of transport 
defects. Moreover, we found that Myt1-depleted cells showed a 
retarded proliferation rate and died within 10 d. Thus, Myt1 is 
likely to be essential for Golgi structure and function. 
  Myt1 might function to maintain Golgi structure during 
interphase, or, alternatively, Myt1 might be essential for Golgi 
  Figure 3.       Depletion of Myt1 induces dramatic 
changes in the Golgi apparatus and ER exit sites.   
HeLa cells were transfected with Myt1 siRNA and 
incubated for 48 h. (A) The cells were stained with 
anti-GM130 and anti-p115 antibodies (red) together 
with Hoechst (blue). High resolution images (GM130) 
were obtained by deconvolution (bottom). (B) The 
cells were stained with anti  –      -adaptin antibody (red) 
together with anti  –  Golgin97 antibody (green) and 
Hoechst (blue). (C) The cells were stained with anti-
Sec31A antibody (red) for ER exit sites together with 
anti-GM130 antibody (green) and Hoechst (blue). 
Bars, 10   μ  m.     93  M  YT  1 IS ESSENTIAL FOR GOLGI AND ER ASSEMBLY   •   NAKAJIMA ET AL.
phenotype persisted through G1 into S and G2 phases (unpub-
lished data). We have also revealed that Golgi restoration after 
brefeldin A washout in Myt1-depleted cells was normal and not 
delayed compared with the restoration in control cells (unpub-
lished data). These results have clearly shown that Myt1 is re-
quired for Golgi reassembly during telophase but not for the 
maintenance of Golgi structure during interphase. 
  Electron microscopy was used to examine the morphol-
ogy of the Golgi apparatus in Myt1-depleted cells. Although the 
as cells progressed through the cell cycle after release from the 
G1/S block. In G2 phase, Myt1-depleted cells had normal ribbon-
like Golgi structures (  Fig. 4 A  , 8 h) in spite of the complete loss 
of Myt1 (  Fig. 1 B  ). Also, the Golgi fragmentation occurred 
normally during prometaphase in Myt1-depleted cells (  Fig. 4 A  , 
11 h). However, in G1 phase after mitosis, the staining pattern 
showed abnormal, markedly condensed, nonribbon-like mem-
branous structures (  Fig. 4 A  , 15 h). Thus, Myt1 depletion induced 
severe defects in Golgi reassembly. We confi  rmed that such a 
  Figure 4.       Myt1 is required for Golgi reassembly during telophase.   (A) Synchronized HeLa cells were transfected with Myt1 siRNA as in   Fig. 1 B  , and cells 
at 8 (G2), 11 (M), and 15 h (G1) after the release were stained with anti-GM130 antibody (red) and Hoechst (blue). (B) Representative electron micros-
copy images of Golgi in cells that were transfected with or without Myt1 siRNA and incubated for 48 h. (C) Immunolabeling electron microscopy images 
of the Golgi area in HeLa cells transfected with or without Myt1 siRNA. For immunolabeling of Golgi marker proteins, monoclonal antibody to GM130 
was used. (B and C) Arrows show cisternae or long tubules. White arrowheads show transport vesicles, and black arrowheads show short tubules and 
vesicles. Bars: (A) 10   μ  m; (B and C) 0.2   μ  m.     JCB • VOLUME 181 • NUMBER 1 • 2008  94 
and abnormal in appearance (  Fig. 4 B  , Myt1 siRNA; right). Two 
types of aberrant membranous structures were observed exclu-
sively in Myt1-depleted cells (  Fig. 4 B  , Myt1 siRNA; left and 
middle). These included structures composed of short tubules 
and an abundance of vesicles (  Fig. 4 B  , Myt1 siRNA; left), 
normally stacked Golgi cisternae could be observed in more 
than three fourths of control cells (  Fig. 4 B  , control), stacked 
Golgi-like cisternae could be detected only in approximately 
one third of Myt1 siRNA-treated cells. Moreover, the stacked 
Golgi-like cisternae in Myt1-depleted cells were loosely stacked 
  Figure 5.       Myt1 is required for ER meshwork formation.   (A) HeLa cells were transfected with Myt1 siRNA and incubated for 48 h. The ER was visualized 
with ER tracker red in living cells without ﬁ  xation. (B) The cells in A were classiﬁ  ed into three types based on the ER morphology. The cells that have a 
ﬁ  ne ER meshwork consisting of typical tubular structures throughout the cytoplasm were classiﬁ  ed into a ﬁ  ne meshwork type (labeled as F). The cells that 
have a coarse ER meshwork and thick, cisternae-like structures in the cell periphery were classiﬁ  ed into a coarse meshwork type (labeled as C). The cells 
that show intermediate phenotypes were classiﬁ  ed into a ﬁ  ne/coarse meshwork type (labeled as F/C). More than 40 cells were examined. The bars are 
the mean of two independent experiments. (C) Synchronized HeLa cells were transfected with Myt1 siRNA as in   Fig. 1 B  , and ER was visualized with ER 
tracker red in living cells at 8 (G2), 11 (M), and 15 h (G1) after the release. (D) The G2 and G1 cells in C are classiﬁ  ed into three types based on the 
ER morphology. More than 45 cells were examined in each experiment, and experiments were performed twice. (B and D) Error bars represent   ±  SD. 
Bars, 10   μ  m.     95  M  YT  1 IS ESSENTIAL FOR GOLGI AND ER ASSEMBLY   •   NAKAJIMA ET AL.
which were likely derived from mitotic Golgi fragments, and 
condensed structures consisting of vesicles surrounded by ab-
normally bended stacks of long tubules (  Fig. 4 B  , Myt1 siRNA; 
middle). Immunoelectron microscopy using an anti-GM130 an-
tibody (  Fig. 4 C  ) revealed that the abnormal membranous struc-
tures were derived from Golgi fragments and may correspond to 
the condensed nonribbon-like membranous structures seen with 
immunofl  uorescence staining (  Fig. 3 A  ). Thus, the electron 
microscopy data support the conclusion that Myt1 functions to 
facilitate Golgi reassembly during telophase. 
  Myt1 is necessary for ER meshwork 
formation during telophase 
  Golgi is closely related to the ER (  Lippincott-Schwartz et al., 
2000  ). The ER is a continuous membrane system enclosing 
a single luminal space and comprises fi  ne tubular networks 
and cisternae throughout the cytoplasm (  Voeltz et al., 2002  ; 
  Shibata et al., 2006  ). ER tracker labeling in live cells revealed 
that a fi  ne ER meshwork became disrupted in Myt1 siRNA-
treated cells; the meshwork of tubular structures became coarse, 
and thick, cisternae-like structures appeared in the cell periph-
ery in Myt1-depleted cells (  Fig. 5 A  ). To semiquantify this 
phenotype, the cells were classifi  ed into three types based on 
the ER morphology. The cells that had a fi  ne ER meshwork 
consisting of typical tubular structures throughout the cyto-
plasm were classifi  ed into a fi  ne meshwork type (  Fig. 5 B  , bars 
labeled F). The cells that had a coarse ER meshwork and thick, 
cisternae-like structures in the cell periphery were classifi  ed 
into a coarse meshwork type (  Fig. 5 B  , bars labeled with C). 
The cells that show intermediate phenotypes were classifi  ed 
into a fi  ne/coarse meshwork type (  Fig. 5 B  , bars labeled with 
F/C). The semiquantifi  cation data in   Fig. 5 B   clearly show that 
Myt1 depletion induces disruption of a fi  ne ER meshwork. 
When synchronized HeLa cells were transfected with Myt1 
siRNA as in   Fig. 1 B  , Myt1-  depleted cells had a normal, fi  ne 
ER meshwork in G2 phase (  Fig. 5, C and D  ; 8 h [G2]) in spite 
of the complete loss of Myt1 (  Fig. 1 B  ), and, during mitosis, 
the ER morphology in Myt1-depleted cells was indistinguish-
able from that in control cells (  Fig. 5 C  , 11 h). However, in G1 
phase after mitosis, ER tracker labeling showed an abnormal 
coarse meshwork of ER (  Fig. 5, C and D  ; 15 h [G1]). Thus, 
Myt1 depletion induced severe defects in reassembly of a fi  ne 
ER meshwork. Therefore, Myt1 is required for reassembly 
of a fi  ne, interphase-type ER meshwork during mitotic exit 
but not for biogenesis or maintenance of an ER meshwork 
during interphase. 
  Kinase activity of Myt1 is necessary for 
Golgi and ER reassembly 
  To ensure that Myt1 siRNA specifi  cally depletes cells of Myt1, 
we performed add-back experiments in synchronized HeLa cells. 
Expression of an siRNA-resistant form of Myt1 almost com-
pletely rescued the Golgi reassembly defect (  Fig. 6 A  , Myt1 
siRNA + Myt1-WT; arrows). In contrast, expression of the 
siRNA-resistant form of Myt1 that lacks kinase activity did 
not rescue the phenotype (  Fig. 6 A  , Myt1 siRNA + Myt1-KD). 
To semiquantify the Golgi defect, GM130-stained images were 
  Figure 6.       Kinase activity of Myt1 is necessary for Golgi reassembly.   
(A) HeLa cells were transfected with or without Myt1-WT or Myt1-KD 
(a kinase-inactive form of Myt1), which is resistant to Myt1 siRNA, together 
with CFP as an indicator of Myt1-expressing cells before the ﬁ  rst thymi-
dine block, and then Myt1 siRNA treatment was performed after the ﬁ  rst 
thymidine block. 15 h after the release from G1/S block, cells were sub-
jected to immunoblotting with anti-Myt1 antibody (top) or were ﬁ  xed and 
stained with anti-GM130 antibody (red; bottom). Exogenous Myt1 levels 
in Myt1-depleted cells were lower than endogenous Myt1 levels in control 
cells (top). We conﬁ  rmed that this level of Myt1 expression did not inhibit 
entry into mitosis (not depicted). Exogenous Myt1 was expressed only in 
CFP-positive cells (blue; bottom), and the Golgi reassembly defect was 
completely rescued by the expression of Myt1-WT (bottom left; arrows). 
(B) The relative Golgi area in anti-GM130 images in the cells described 
in A were measured (see Materials and methods). The percentage of cells 
whose Golgi area was smaller than one SD from the mean Golgi area of 
control cells was determined. More than 200 cells were examined in each 
experiment, and experiments were performed twice. The results obtained 
from each independent experiment are represented as distinct bars (gray 
and black bars for each experiment). Bar, 10   μ  m.     JCB • VOLUME 181 • NUMBER 1 • 2008  96 
  Myt1 functions to facilitate Golgi and 
ER assembly through both cyclin B1 
and cyclin B2 
  Cdc2 is the only known substrate of Myt1 (  Booher et al., 1997  ). 
Cdc2 is bound to mitotic B-type cyclins and is then activated 
to form M phase  –  promoting factor (  Nurse, 1990  ;   Hunt, 1991  ). 
There are three mammalian B-type cyclins: cyclin B1, B2, and 
B3. Among these B-type cyclins, mammalian cyclin B3 is 
thought to be a meiosis-specifi  c cyclin because it is detected in 
both the testis and ovary but not in any other tissues. The mRNA 
and the protein of human cyclin B3 could not be detected in 
HeLa cells (  Nguyen et al., 2002  ). In contrast, cyclin B1 and cy-
clin B2 are ubiquitously present in somatic cells, and both pro-
tein levels peak at M phase (  Pines, 1999  ). In our analysis in 
synchronized HeLa cells, cyclin B1 was mostly degraded during 
metaphase and anaphase (at     10 h after release in this series of 
experiments) as previously reported (  Clute and Pines, 1999  ), but 
the protein appeared to be present at very low levels even in late 
mitosis (at     11  –  12 h;   Fig. 8 A  ). In the same series of experi-
ments, cyclin B2 was also mostly degraded after metaphase, 
but low levels, which were slightly higher than cyclin B1 levels, 
  Figure 7.       Kinase activity of Myt1 is necessary 
for ER reassembly.   (A) HeLa cells were trans-
fected with or without Myt1-WT or Myt1-KD, 
which is resistant to Myt1 siRNA, together with 
CFP as an indicator of Myt1-expressing cells 
before the ﬁ  rst thymidine block, and then Myt1 
siRNA treatment was performed after the ﬁ  rst 
thymidine block. ER was visualized with ER 
tracker red in living cells 15 h after the release. 
(B) CFP-positive cells in A were classiﬁ  ed into 
three types based on the ER morphology as 
described in   Fig. 5 B  . More than 32 cells were 
examined in each experiment, and experi-
ments were performed twice or more. The bars 
are the mean of more than two independent 
experiments. Error bars represent   ±  SD. F, ﬁ  ne 
meshwork type; C, coarse meshwork type; 
F/C, ﬁ  ne/coarse meshwork type. Bar, 10   μ  m.     
used to measure the Golgi area in Myt1-depleted and -restored 
cells. 19% of control cells and 52% of Myt1-depleted cells had 
a Golgi area smaller than one SD from the mean measured in 
control cells (  Fig. 6 B  ). Expression of Myt1 in Myt1-depleted 
cells reduced the percentage of small, compact Golgi from 52 to 
16% (  Fig. 6 B  ), indicating an almost complete rescue of the 
phenotype. Expression of kinase-inactive Myt1 was unable to 
restore the integrity of the Golgi (43% of control;   Fig. 6 B  ). 
These results demonstrate that the kinase activity of Myt1 is 
required for Golgi reassembly. 
  The Myt1 add-back experiments were also performed to 
examine the ER morphology in synchronized HeLa cells. When 
the siRNA-resistant form of Myt1 was expressed in Myt1 
siRNA-treated cells, the ER reassembly defect, that is, the de-
fect in reassembly of an interphase-type ER meshwork during 
telophase, was mostly rescued, and a fi  ne ER meshwork ap-
peared (  Fig. 7, A and B  ; Myt1 siRNA + Myt1-WT). In contrast, 
expression of the siRNA-resistant form of Myt1 that lacks 
kinase activity did not rescue the ER reassembly defect (  Fig. 7, 
A and B  ; Myt1 siRNA + Myt1-KD). Thus, the kinase activity 
of Myt1 is also required for ER reassembly. 97  M  YT  1 IS ESSENTIAL FOR GOLGI AND ER ASSEMBLY   •   NAKAJIMA ET AL.
  –  cyclin B2 together with DsRed  –  histone H1 and were monitored 
during mitosis by time-lapse video microscopy. We confi  rmed 
that the protein levels of GFP  –  cyclin B1 and GFP  –  cyclin B2 
were comparable with, or, at most, were less than three times the 
remained in late M phase and even early G1 phase (  Fig. 8 A  ). 
To examine the levels of cyclin B1 and cyclin B2 in more detail, we 
performed time-lapse video microscopy experiments. Synchro-
nized HeLa cells were transfected with GFP  –  cyclin B1 or 
  Figure 8.       Residual cyclin B  –  Cdc2 during mitotic exit.   (A) Extracts from HeLa cells synchronized by a double-thymidine block were analyzed by SDS-
PAGE followed by immunoblotting with anti  –  cyclin B1, anti  –  cyclin B2, and anti  –      -tubulin antibodies. (B) HeLa cells were transfected with GFP  –  cyclin B1 
or GFP  –  cyclin B2 together with DsRed  –  histone H1 and were monitored by time-lapse video microscopy. Time-lapse sequences taken every 5 min from 
metaphase to mitotic exit are shown. These data are representative of   >  10 cells in separate experiments. Time is given in minutes. (C) Extracts from HeLa 
cells synchronized by a double-thymidine block were analyzed by immunoprecipitation with antibody against cyclin B1 followed by immunoblotting with 
antibodies against Cdc2 and cyclin B1. The image with short exposure time on the same gel is shown in the right panel. (D) HeLa cells were transfected 
with or without Myt1 siRNA in the interval between the two thymidine blocks. The cell extracts were subjected to immunoblotting with antiphospho-Ser25-
GM130, anti-GM130, anti-Myt1, and anti  –  cyclin B1 antibodies. (E) Myc-tagged Myt1 was coexpressed with GFP  –  cyclin B2, and the cells were analyzed 
by immunoprecipitation with antibody against Myc followed by immunoblotting with antibodies against GFP and Myc (top). HeLa cells that were synchro-
nized by a double-thymidine block were treated with 125 ng/ml nocodazole 8.5 h after the release and were harvested up to 12 h to gather mitotically 
arrested cells. The cells were analyzed by immunoprecipitation with antibody against cyclin B2 followed by immunoblotting with antibodies against cyclin 
B2 and Myt1 (bottom). Bar, 10   μ  m.     JCB • VOLUME 181 • NUMBER 1 • 2008  98 
in synchronized HeLa cells by immunoblotting. The decreased 
gel mobility of Cdc2 is known to be caused by the phosphory-
lation of Thr14 and Tyr15 (  Norbury et al., 1991  ;   Solomon et al., 
1992  ). The obtained results have clearly demonstrated that 
Cdc2, which was coprecipitated with cyclin B1, was mostly 
phosphorylated on both Thr14 and Tyr15 in late G2 at 9 h, and 
the major population of Cdc2 was the dephosphorylated form at 
the onset of mitosis at 10 h (  Fig. 8 C  ). Most importantly, just 
before cyclin B1 disappeared in late mitosis, the amount of 
phosphorylated Cdc2 became similar to or greater than that of 
unphosphorylated Cdc2 (at 13 h;   Fig. 8 C  ). In seven indepen-
dent experiments, we obtained similar results. Consistent with 
our results,   Jin et al. (1998  ) previously showed that when a sta-
bilized form of cyclin B1 was expressed in synchronized HeLa 
cells, Cdc2 phosphorylation was increased during mitotic exit, 
and the cells were capable of exiting mitosis. Thus, our results 
and the results of   Jin et al. (1998  ) strongly suggest that there is 
levels of endogenous cyclin B1 and cyclin B2, respectively (un-
published data). Although GFP  –  cyclin B1 began to be degraded 
at metaphase as previously reported (  Clute and Pines, 1999  ), 
GFP  –  cyclin B2 began to be degraded after metaphase (  Fig. 8 B  ). 
Most importantly, low but signifi  cant levels of both GFP  –  cyclin 
B1 and GFP  –  cyclin B2 persisted even in anaphase and telophase 
(  Fig. 8 B  ). These data suggest that when Golgi and ER reassem-
bly occur during telophase, low levels of B-type cyclins are 
present as partners of Cdc2. As Cdc2 activity plays a role in 
promoting Golgi disassembly and ER network reorganization to 
the M-phase type during early mitosis, it is likely that the kinase 
activity of Cdc2 must be suppressed during telophase; otherwise, 
the kinase activity would prevent Golgi and ER reassembly. 
We hypothesized that Myt1 inhibits Cdc2 activity during telophase. 
  If our hypothesis is correct, Cdc2 would be phosphorylated 
on Thr14/Tyr15 during mitotic exit. To address this, we examined 
the phosphorylation state of Cdc2 in the cyclin B1  –  Cdc2 complex 
  Figure 9.       Golgi fragmentation/reassembly and morphological changes of ER occur almost normally during mitosis in cyclin B1/cyclin B2 double siRNA  –
  treated cells.   HeLa cells were transfected with cyclin B1 and cyclin B2 siRNAs in the interval between the two thymidine blocks. (A) The cells at 8 (G2), 11 
(metaphase and anaphase), and 18 h (G1) after the release were stained with anti-GM130 antibody (red) and Hoechst (blue). (B) ER was visualized with 
ER tracker red in living cells at 8 (G2), 11  –  12 (metaphase and anaphase), and 18 h (G1) after the release. Bars, 10   μ  m.     99  M  YT  1 IS ESSENTIAL FOR GOLGI AND ER ASSEMBLY   •   NAKAJIMA ET AL.
  Discussion 
  In this study, we have examined the role of Myt1 in mammalian 
somatic cell cycles. We fi  rst show that inhibition of Myt1 ex-
pression by siRNA in HeLa cells does not change the timing of 
mitotic entry but rather induces severe defects in the morphology 
of the Golgi and ER, resulting in abnormally condensed Golgi 
structures and disrupted ER meshwork. Our results then show 
that the Golgi and ER morphology defects are observed after the 
cells pass through mitosis. These results demonstrate that Myt1 
is required for Golgi and ER reassembly during mitotic exit, not 
for the biogenesis or maintenance of Golgi and ER structures 
during interphase. Moreover, our fi  nding that add back of wild-
type but not kinase-inactive Myt1 rescues the Golgi and ER re-
assembly defects seen in Myt1-depleted cells demonstrates that the 
kinase activity of Myt1 is required for Golgi and ER reassembly. 
Myt1 is known to bind to cyclin B1, and here it is shown to bind 
to cyclin B2 as well. Remarkably, inhibition of both cyclin B1 
and cyclin B2 expression by siRNAs markedly rescues the Myt1 
siRNA-induced Golgi and ER reassembly defects. These results 
strongly suggest that Myt1 functions to facilitate Golgi and ER 
reassembly during mitotic exit by suppressing both cyclin B1  –   
and cyclin B2  –  Cdc2 activities. We have also found that Wee1 
siRNA-treated HeLa cells enter mitosis much earlier than the 
control and Myt1 siRNA-treated cells. However, it has previ-
ously been reported that expression of Cdc2AF (a mutant form 
of Cdc2 in which Thr14 and Tyr15 are changed to Ala and Phe) 
in HeLa cells to levels that markedly elevate histone H1 activity 
does not advance the timing of nuclear envelope breakdown or 
chromatin condensation (  Blasina et al., 1997  ;   Jin et al., 1998  ). 
This result indicates that the activation of Cdc2 is not suffi  cient 
to induce nuclear envelope breakdown or chromatin condensa-
tion. Therefore, we may speculate that Wee1 has an additional 
role. For example, Wee1 might inhibit the nuclear accumulation 
of cyclin B1  –  Cdc2, or Wee1 might inhibit cyclin B  –  Cdc2 by its 
direct interaction. Future studies are needed to analyze the pheno-
types of Wee1 knockdown cells in more detail. 
  Mitotic Golgi fragmentation and reassembly are crucial 
events in mammalian cells. Golgi fragmentation is thought to 
facilitate the equal partitioning of Golgi membranes between 
the two daughter cells during cell division (  Shorter and Warren, 
2002  ) and has recently been reported to be important for mitotic 
progression (  Sutterlin et al., 2002  ;   Hidalgo Carcedo et al., 
2004  ). Golgi reassembly, then, is an essential process for estab-
lishing a functional Golgi apparatus ( Shorter and Warren, 2002 ). 
Mitotic Golgi fragmentation in mammalian cells is dependent 
on Cdc2 (  Lowe et al., 1998  ). Golgi proteins such as GM130, 
GRASP65, p47, and Rab1, which play a crucial role in hetero-
typic or homotypic membrane fusion or stacking of Golgi cis-
ternae, are substrates of Cdc2 ( Shorter and Warren, 2002 ). Cdc2-
mediated phosphorylation of these Golgi proteins is expected 
to promote mitotic Golgi disassembly through the cessation 
of vesicle transport and unstacking of existing cisternae. Thus, 
during telophase, these phosphoproteins must be dephosphory-
lated for proper Golgi reassembly to occur. Therefore, the 
active Cdc2 would need to be inactivated during telophase to 
ensure Golgi reassembly. Our results with cyclin B1 and cyclin 
an increase in phospho-Thr14/Tyr15 of Cdc2 during mitotic 
exit. Furthermore, we have revealed that the phosphorylation of 
GM130 on Ser25, which is one of the targets of Cdc2 on the 
Golgi (  Lowe et al., 1998, 2000  ), persisted for a prolonged pe-
riod during mitotic exit in synchronized Myt1-depleted HeLa 
cells compared with control cells (  Fig. 8 D  ). This result sug-
gests that residual cyclin B – Cdc2 should be suppressed by Myt1 
during mitotic exit. 
  It has previously been shown that Myt1 associates with 
cyclin B1 (  Liu et al., 1999  ). Thus, we tested whether Myt1 as-
sociates with cyclin B2 as well. When Myc-tagged Myt1 was 
coexpressed with GFP  –  cyclin B2, Myc-Myt1 coprecipitated 
with GFP  –  cyclin B2 (  Fig. 8 E  , top). Moreover, Myc-Myt1 co-
localized with GFP  –  cyclin B2 (unpublished data). In addition, 
endogenous Myt1 coprecipitated with endogenous cyclin B2 in 
mitotic HeLa cells (  Fig. 8 E  , bottom). These results suggest that 
both cyclin B1  –  Cdc2 and cyclin B2  –  Cdc2 could be targets of 
Myt1 and that both activities might be suppressed by Myt1 dur-
ing Golgi and ER reassembly at the end of mitosis. To test this, 
we inhibited cyclin B1 and cyclin B2 expression by siRNA in 
Myt1 siRNA-treated and untreated asynchronous HeLa cells 
(see Fig. 10 A). Although the single siRNA treatment for each 
target almost completely depleted the cells of the target, it was 
diffi  cult to fi  nd the conditions in which the triple siRNA treat-
ment for cyclin B1, cyclin B2, and Myt1 could almost com-
pletely abolish the expression of three proteins. Thus, under the 
conditions we used here, cyclin B1 expression was almost com-
pletely inhibited, but low levels of Myt1 and cyclin B2 ex-
pression remained (see Fig. 10 A). However, this level of Myt1 
down-regulation (    90% depletion) induced the Golgi and ER 
morphology defects (see Fig. 10, B and C), which were indistin-
guishable from those resulting from the almost complete loss 
of Myt1, as shown in   Figs. 3 A and 5 A  . Cyclin B1 and/or cyclin 
B2 down-regulation in combination or alone in Myt1 siRNA-
untreated cells had little effect on the Golgi and ER morphology 
both in interphase and in M phase; that is, even in cyclin 
B1/cyclin B2 double siRNA  –  treated synchronized HeLa cells, 
the Golgi fragmentation and reassembly during mitosis occurred 
almost normally (  Fig. 9 A  ), and ER meshwork changes during 
mitosis also occurred almost normally (  Fig. 9 B  ), although a 
signifi  cant proportion (    30%) of cyclin B1/cyclin B2 double 
siRNA  –  treated cells displayed micronuclei or multinuclei (  Fig. 
10 B   and not depicted). Either cyclin B1 or cyclin B2 down-
regulation in Myt1 siRNA-treated cells partially rescued the 
Golgi and ER morphology defects seen in Myt1-depleted cells. 
Remarkably, both cyclin B1 and cyclin B2 down-regulation 
almost completely rescued the defects (  Fig. 10, B  –  D  ); in the 
Myt1/cyclin B1/cyclin B2 triple siRNA  –  treated cells, the Golgi 
apparatus resumed a normal ribbonlike appearance (  Fig. 10 B  ), 
and ER resumed a fi  ne interphase-type meshwork (  Fig. 10, 
C and D  ). The signifi  cant proportion of Myt1/cyclin B1/B2 triple 
siRNA  –  treated cells also displayed micronuclei or multinuclei. 
Even in these cells, the normal ribbonlike appearance of the 
Golgi apparatus and fi  ne ER meshwork was almost completely 
restored ( Fig. 10, B – D ). These results strongly suggest that Myt1 
facilitates Golgi and ER reassembly by suppressing both cyclin 
B1 –   and  cyclin  B2 – Cdc2  activities. JCB • VOLUME 181 • NUMBER 1 • 2008  100 
B2 down-regulation experiments strongly suggest that Myt1 
facilitates Golgi reassembly through inhibition of both cyclin 
B1  –   and cyclin B2  –  Cdc2 activities during telophase. 
  ER is a continuous membrane system enclosing a single 
luminal space and comprises tubular networks and cisternae 
throughout the cytoplasm ( Voeltz et al., 2002 ;  Shibata et al., 2006 ). 
  Figure 10.       Myt1 functions to facilitate Golgi and ER assembly through both cyclin B1 and cyclin B2.   HeLa cells were transfected with Myt1, cyclin B1, or 
cyclin B2 siRNA (alone or in combination) and incubated for 48 h. (A) The cells were subjected to immunoblotting with antibodies against Myt1, cyclin B1, 
cyclin B2, and     -tubulin. (B) The cells were ﬁ  xed and stained with anti-GM130 antibody (red) and Hoechst (blue). (C) ER was visualized with ER tracker red in 
living HeLa cells. (D) The cells in C were classiﬁ  ed into three types based on the ER morphology as described in   Fig. 5 B  . More than 45 cells were examined 
in each experiment, and experiments were performed more than twice. The cells were subjected to immunoblotting with antibodies against Myt1, cyclin B1, 
cyclin B2, and     -tubulin. Error bars represent   ±  SD. F, ﬁ  ne meshwork type; C, coarse meshwork type; F/C, ﬁ  ne/coarse meshwork type. Bars, 10   μ  m.     101  M  YT  1 IS ESSENTIAL FOR GOLGI AND ER ASSEMBLY   •   NAKAJIMA ET AL.
B2  –  Cdc2 activities during mitotic exit for proper Golgi and ER 
reassembly to occur, although we cannot exclude the possibility 
that Myt1 has other unidentifi  ed targets. 
  Our results also suggest that Myt1-mediated suppression 
of cyclin B1  –   and cyclin B2  –  Cdc2 activities may not be indis-
pensable for the regulation of a broad range of mitotic events, 
such as regulation of mitotic entry timing and spindle assembly, 
although we cannot exclude the possibility that the depletion of 
Myt1 was insuffi  cient to yield the phenotype. However, it is 
certain that the effect of Myt1 depletion was primarily seen in 
Golgi and ER reassembly, not in mitotic entry timing. How can 
such a difference of the effects of Myt1 depletion arise? It does 
not seem to depend on the cyclin-type specifi  city of Myt1 be-
cause Myt1 inhibits not only cyclin B1  –  Cdc2 activity but also 
cyclin A2 – Cdc2 activity in vitro ( Booher et al., 1997 ). We specu-
late that the inhibitory effect of Myt1 toward Cdc2 may not be 
strong enough to inhibit the whole population of cyclin  –  Cdc2 
complexes at G2/M phase, in which total A- and B-type cyclins 
are abundant. In contrast, because the protein levels of Cdc2  –
  cyclins are very low in late mitosis, Myt1 may inhibit Cdc2 ac-
tivity completely, and the effect of Myt1 may become prominent 
in this period. Thus, we think that the difference of the effects of 
Myt1 on mitotic entry timing and Golgi/ER reassembly may 
arise from the limited inhibitory effect of Myt1 toward Cdc2. 
In summary, we have revealed that Myt1 is required for the con-
trol of intracellular membrane dynamics such as Golgi and ER 
re  assembly during mitosis in mammalian somatic cell cycles. 
  Materials and methods 
  Cell culture and synchronization 
  HeLa cells were cultured in DME containing 10% FBS or 10% calf serum. 
To synchronize cells, HeLa cells were arrested at the G1/S boundary by a 
double-thymidine block and were released from the arrest by washing with 
fresh medium. 50   μ  M MG132 (EMD) was added into the medium 8 h after 
the release from double-thymidine block and was incubated. For transfec-
tion with DNA vectors and siRNAs during synchronization, cells were 
transfected with DNA vectors in Opti-MEM with the use of Lipofectamine 
Plus (Invitrogen) for 1 h and were washed into fresh medium containing 
thymidine for the ﬁ  rst block. Then, cells were transfected with siRNAs by 
the use of Oligofectamine (Invitrogen) after the ﬁ  rst thymidine block. For 
time-lapse imaging, synchronized HeLa cells were transfected with DNA 
vectors in Opti-MEM with the use of Lipofectamine Plus for 1 h and were 
washed into fresh medium containing thymidine for the second block. 
  Immunoblotting 
  Cells were lysed in lysis buffer (50 mM Tris, pH 8.0, 100 mM NaCl, 5 mM 
EDTA, 0.5% NP-40, 2 mM DTT, 1 mM PMSF, 1 mM Na  3  VO  4  , and 2   μ  g/ml 
aprotinin) and centrifuged at 20,000   g   for 15 min. The cell extracts were 
subjected to immunoblotting with anti-Myt1 (  Liu et al., 1997  ), anti  –  cyclin 
B1 (Santa Cruz Biotechnology, Inc.), anti  –      -tubulin (Sigma-Aldrich), anti-
Wee1 (Santa Cruz Biotechnology, Inc.), anti  –  cyclin B2 (Santa Cruz Bio-
technology, Inc.), anti-Cdc2 (Santa Cruz Biotechnology, Inc.), anti  –  c-Myc 
(Santa Cruz Biotechnology, Inc.), antiphospho-Ser25-GM130 (provided 
by M. Lowe, University of Manchester, Manchester, UK;   Lowe et al., 
2000  ), anti-GM130 (BD Biosciences), or anti-GFP antibody (Living Colors; 
BD Biosciences). 
  Phosphatase treatment 
  Cells were lysed in phosphatase buffer (50 mM Hepes, pH 7.5, 100 mM 
NaCl, 0.1 mM EGTA, 0.5% NP-40, 2 mM DTT, 1 mM PMSF, 2 mM MnCl  2  , 
and 2   μ  g/ml aprotinin) and centrifuged at 20,000   g   for 15 min. The cell 
extracts were incubated with 300 U of puriﬁ  ed       protein phosphatase 
(New England Biolabs, Inc.) for 45 min at 30  °  C. The phosphatase reaction 
was stopped by the addition of the SDS sample buffer. Samples were ana-
lyzed by immunoblotting. 
Even during mitosis, the continuity of the luminal side of the 
organelle is maintained (  Ellenberg et al., 1997  ;   Terasaki, 2000  ). 
However, the precise structural features of the ER network in 
mitotic cells are less clear. The round shape of mitotic cells 
makes it diffi  cult to observe the precise structures of the ER. 
In this study, we show that Myt1 is essential for ER meshwork 
formation during mitotic exit but not for its maintenance in 
interphase. This result suggests that ER may undergo dynamic 
morphological changes during mitosis. Furthermore, our data 
show that Myt1 facilitates reassembly of a fi  ne interphase-type 
ER meshwork during mitotic exit through inhibition of cyclin 
B1 and cyclin B2. This fi  nding suggests that Cdc2 activity may 
play a pivotal role in dynamic morphological changes of ER 
during mitosis. Previous studies also suggested that Cdc2 might 
be involved in the regulation of ER morphology (  Dreier and 
Rapoport, 2000  ;   Kano et al., 2005  ). In semi-intact cells, an elab-
orate meshwork of ER is disrupted by a mitotic cytosol, and 
the disruption is dependent on Cdc2 kinase (  Kano et al., 2005  ). 
In vitro, de novo formation of ER meshwork from microsomal 
vesicles occurs in interphase extracts but not in Cdc2 kinase  – 
activated interphase extracts ( Dreier and Rapoport, 2000 ). Thus, 
Cdc2 activity has the ability to disrupt the elaborate ER mesh-
work. These results are in agreement with our idea that Myt1-
mediated inhibition of Cdc2 activity during mitotic exit is 
important for the formation of an elaborate ER meshwork. 
  Cdc2 activities associated with B-type cyclins have been 
thought to play an important role in inducing a broad range of 
mitotic events, including mitotic Golgi fragmentation. How-
ever, our results show that even when both cyclin B1 and cyclin 
B2 expression are inhibited, the Golgi fragmentation and re-
assembly during mitosis occur almost normally, and ER mesh-
work changes during mitosis also occur almost normally (  Fig. 9  ). 
These observations suggest that cyclin B1 and cyclin B2 are 
dispensable for Golgi fragmentation and ER reorganization dur-
ing early mitosis. Most recently, Gong et al. (  2007  ) reported 
that the timing of nuclear envelope breakdown was affected 
very little by knocking down both cyclin B1 and cyclin B2 but 
was markedly delayed by knocking down cyclin A2. Gong et al. 
(  2007  ) then also concluded that cyclin A2 is crucial for nuclear 
envelope breakdown. Thus, it is likely that cyclin A2, both in 
the absence or presence of cyclin B1 and cyclin B2, may play a 
pivotal role in Golgi disassembly and ER network reorganiza-
tion during mitosis, although it is also possible that very low 
levels of cyclin B1 and cyclin B2, which remain in cyclin B1/
cyclin B2 double siRNA  –  treated cells, play a role in these pro-
cesses in combination with cyclin A2. Cyclin A2, which is thus 
implicated in the early mitotic events, is always degraded before 
cyclin B1 and cyclin B2 (  den Elzen and Pines, 2001  ). Although 
cyclin B1 and cyclin B2 are mostly degraded at metaphase/ 
anaphase, both cyclin B1 and cyclin B2 proteins appear to be 
pres  ent at very low levels during late mitosis (  Fig. 10 A  ). 
Thus, when Golgi and ER reassembly occur during telophase, 
the low levels of B-type cyclins are present as partners of 
Cdc2. Because the kinase activity of the remaining cyclin B1  –   
and cyclin B2  –  Cdc2 would prevent Golgi and ER reassembly, 
their activities must be suppressed during mitotic exit. Our re-
sults suggest that Myt1 might inhibit both cyclin B1  –   and cyclin JCB • VOLUME 181 • NUMBER 1 • 2008  102 
Cell lysates were incubated for 2 h at 4  °  C with anti  –  cyclin B1, anti  –  c-Myc, 
or anti  –  cyclin B2 antibody (Santa Cruz Biotechnology, Inc.), and protein A  – 
Sepharose beads (GE Healthcare) were added and incubated for 2 h. 
The precipitates were then washed three times with lysis buffer. The proteins 
were separated by SDS-PAGE and analyzed by immunoblotting. 
  Electron microscopy 
  Transmission electron microscopic observations were conducted as de-
scribed previously (  Yonemura et al., 1995  ). For immunolabeling, HeLa cells 
were ﬁ  xed for 10 min with 4% PFA and permeabilized for 10 min with 
0.002% saponin in PBS. Cells were blocked for 1 h with 3% BSA, incu-
bated overnight with anti-GM130 antibody, and washed. After incubation 
with 1.4-nm colloidal gold-conjugated secondary antibodies (Nanoprobe), 
samples were ﬁ  xed with 1% glutaraldehyde in 0.1 M phosphate buffer, pH 
7.4, for 10 min, and the gold particles were intensiﬁ  ed by use of an HQ sil-
ver kit (Nanoprobe). The samples were postﬁ  xed in 0.1% osmium tetroxide 
for 90 min on ice, stained with 0.5% uranyl acetate for 2 h, dehydrated 
through graded concentrations of ethanol, and embedded in epoxy resin. 
  Golgi area 
  Anti-GM130 antibody staining images were obtained using a DeltaVision 
Image Restoration microscope with SoftWoRx software. All images were 
taken in the same exposure time. Using Photoshop, the acquired images 
were binarized to white and black using the ﬁ  xed threshold in all samples 
in each experiment. The white area represents the Golgi apparatus, and 
white pixels were measured as relative Golgi area. 
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  Cell staining and microscopy 
  Cells were ﬁ  xed for 10 min with 3.7% formaldehyde and permeabilized for 
10 min with 0.5% Triton X-100 in PBS. Cells were blocked for 1 h with 3% 
BSA, incubated overnight with primary antibodies (anti-GM130 and anti-
p115 antibodies were purchased from BD Biosciences; anti-LAMP1 antibody 
was purchased from Santa Cruz Biotechnology, Inc.; antiphosphohistone H3 
antibody was obtained from Millipore; anti  –      -adaptin and anti  –      -tubulin anti-
bodies were purchased from Sigma-Aldrich; and anti-Myt1 [  Liu et al., 1997  ] 
and anti-Sec13 [  Kano et al., 2004  ] antibodies were described previously), 
washed, and incubated for 1 h with secondary antibodies (AlexaFluor488 or 
594 goat anti  –  mouse or anti  –  rabbit IgG antibodies; Invitrogen). To stain the 
actin cytoskeleton, AlexaFluor546 phalloidin was used. For ER tracker 
(Invitrogen) labeling, cells were incubated with 1   μ  M ER tracker red for 30 min 
before imaging without ﬁ  xation. Images of   Fig. 3   A (left) and   Fig. 4   A were 
acquired using a microscope (Axiophot2; Carl Zeiss, Inc.), a 63  ×   1.4 NA oil 
objective lens (Carl Zeiss, Inc.), a CCD camera (Quantix 1400-G2; Photo-
metrics), and IPLab Spectrum software (BD Biosciences). All other images 
were acquired using the DeltaVision system (Applied Precision) equipped 
with an inverted microscope (IX71; Olympus), a 60  ×   1.4 NA oil objective 
lens (Olympus), a CCD camera (CoolSNAP HQ Monochrome; Photo-
metrics), and SoftWoRx software (Applied Precision). In the images of   Figs. 2  , 
  3   (A [right] and C),   5 (A and C)  ,   7 (A)  ,   9,   and   10 (B and C)  , deconvolving 
images were performed by using SoftWoRx. Image analysis was performed 
using either SoftWoRx or Photoshop (Adobe). Time-lapse images were ac-
quired by using a DeltaVision Image Restoration microscope with SoftWoRx 
software with a temperature-controlled stage. During acquisition, cells 
were cultured at 37  °  C in the medium with 20 mM Hepes, pH 7.3, in glass-
bottom chambers. The cells at prophase and prometaphase were subjected 
to the time-lapse imaging. Time-lapse images were taken every 5 min. 
  siRNA and add-back experiment 
  RNA oligonucleotides (21 nucleotides) homologous to human Myt1, cyclin 
B1, and cyclin B2 were designed as follows: Myt1 forward (5    -GUGACAU-
CAACUCAGAGCCTT-3    ) and Myt1 reverse (5    -GGCUCUGAGUUGAU-
GUCACTT-3    ); cyclin B1 forward (5    -UGAAGAUUCUAAGAGCUUUTT-3    ) 
and cyclin B1 reverse (5    -AAAGCUCUUAGAAUCUUCATT-3    ); and cyclin 
B2 forward (5    -GAGAAUCUCUGCCAAGCUUTT-3    ) and cyclin B2 reverse 
(5    -AAGCUUGGCAGAGAUUCUCTT-3    ). Cells were transfected with an-
nealed siRNAs by the use of Oligofectamine (Invitrogen). In   Figs. 1  –  8  , cells 
grown in a six-well dish were transfected with 200 pmol Myt1 or Wee1 
siRNA. In these conditions, single siRNA treatment for each target almost 
completely depleted the cells of the target (  Figs. 1 B and 6 A  ). However, 
it was difﬁ  cult to ﬁ  nd the conditions in which the triple siRNA treatment for 
Myt1, cyclin B1, and cyclin B2 could almost completely abolish the expres-
sion of three proteins. In   Fig. 10  , cells were transfected with 400 pmol 
Myt1 siRNA, 100 pmol cyclin B1 siRNA, and 20 pmol cyclin B2 siRNA 
for the triple siRNA treatment. In this condition, cyclin B1 expression was 
almost completely inhibited, but low levels of Myt1 and cyclin B2 expres-
sion remained (  Fig. 10 A  ). We found that when cells were transfected with 
100 pmol of single Myt1 siRNA, the remaining Myt1 protein levels were 
the same as the remaining Myt1 levels in Myt1/cyclin B1/cyclin B2 triple 
siRNA  –  treated cells (  Fig. 10 A  ), and this level of Myt1 down-regulation 
(    90% depletion) induced the Golgi and ER morphology defects (  Fig. 10, 
B and C  ), which were indistinguishable from those resulting from the almost 
complete loss of Myt1. In   Fig. 10  , cells were transfected with 200 pmol 
Myt1 siRNA and 100 pmol cyclin B1 siRNA for the double siRNA treatment 
for Myt1 and cyclin B1 and were transfected with 400 pmol Myt1 siRNA 
and 20 pmol cyclin B2 siRNA for the double siRNA treatment for Myt1 and 
cyclin B2. Also, in   Figs. 9   and   10  , cells were transfected with 100 pmol cy-
clin B1 siRNA and 20 pmol cyclin B2 siRNA for the double siRNA treatment 
for cyclin B1 and cyclin B2. In all siRNA experiments in this manuscript, 
control means the procedure without siRNA. We also conﬁ  rmed that there 
was no change in the Golgi and ER morphology when we used Luciferase 
siRNA as control siRNA. Silent mutations in the siRNA-targeting region 
of Myt1 were introduced by PCR-based mutagenesis using the following 
primers: forward (5    -GACATCAACTC  T  GA  A  CCTCCTCGGGGCTC-3    ; bold 
nucleotides indicate silent mutations) and reverse (5    -GAGCCCCGAG-
GAGGTTCAGAGTTGATGTC-3    ). For add-back experiments, the cells were 
transfected with 0.02   μ  g pCDNA3 vector harboring the siRNA-resistant 
form of Myt1 together with 0.5   μ  g pECFP vector in Opti-MEM with the use 
of Lipofectamine Plus for 1 h before the ﬁ  rst thymidine block. 
  Immunoprecipitation 
  Transient transfection with GFP  –  cyclin B2 and Myc-Myt1 was performed using 
FuGENE6 (Roche) according to the manufacturer  ’  s instructions. For immuno-
precipitation experiments, cells were lysed in lysis buffer and homogenized. 103  M  YT  1 IS ESSENTIAL FOR GOLGI AND ER ASSEMBLY   •   NAKAJIMA ET AL.
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